The abstract submission is now closed!
View the abstracts in the online programme
Abstract submission deadlines
Deadline |
Date and time |
|---|---|
Abstracts |
9 April 2024, 21:00hrs CEST |
Late-breaking abstracts (LBA) |
6 June 2024, 21:00hrs CEST |
Abstract submission categories
- Colon cancer
- Rectal cancer
- Upper digestive – Biliary, ampullary and pancreatic cancer
- Upper digestive – Esophageal and gastric cancers
- Hepatocellular and non-biliary liver cancer
- Rare GI cancers (GEP-NETs, endocrine pancreatic, duodenal cancer, anal cancer, etc)
- Miscellaneous
Late-breaking abstracts
Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.
The final late-breaking abstract deadline of 6 June 2024 is under no circumstances to be considered as an extension of the general submission deadline.
Trial in progress abstracts (TiP)
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Gastrointestinal Cancers Congress 2024.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Outcome notifications
Outcome notifications are expected to be made available to first authors and submitters by end-April.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by 10 June 2024.
Information for presenters
Detailed instructions for the preparation of slide presentations and/or posters will be made available by end-April in the section “Information for Presenters”.
Presentation and publication of accepted abstracts
The ESMO Gastrointestinal Cancers 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available onsite for Q&A to represent their work.
All accepted abstracts will be published online only in the ESMO Gastrointestinal Cancers 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.
Publication schedule for accepted abstracts
Details regarding the publication of accepted abstracts are available here.
ESMO Merit Travel Grants
A limited number of ESMO Merit Travel Grants to ESMO Gastrointestinal Cancers 2024 have been made available (upon application), and awarded to the following abstract presenters:
- Margherita Ambrosini, Paris, France
- Alessandro Audisio, Anderlecht, Belgium
- Debora Basile, Crotone, Italy
- Giacomo Bregni, Anderlecht, Belgium
- Silvia Camera, Milan, Italy
- Martina Carullo, Pisa, Italy
- Veronica Conca, Pisa, Italy
- Darren Cowzer, New York, NY, USA
- Virginia Genovesi, Pisa, Italy
- Giada Grelli, Pisa, Italy
- Kin Nam Kwok, Hong Kong SAR, China
- Midhun Malla, Birmingham, AL, USA
- Valentino Martelli, Barcelona, Spain
- Giulia Martini, Naples, Italy
- Gianluca Mauri, Milan, Italy
- Ronan McLaughlin, Toronto, ON, Canada
- Gordon Moffat, Toronto, ON, Canada
- Alberto Puccini, Rozzano, Italy
- Federico Rossari, Milan, Italy
- Nicolas Roussot, Dijon, France
- Abdelrahman Yousef, Houston, TX, USA